Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kümmell's Disease Patients with Severe Osteoporosis
Objective To compare the preventive effects of teriparatide and alendronate on the progression of vertebral body collapse in postmenopausal single‐level Kümmell's disease (KD). Methods From March 2013 to December 2020, the medical records for 53 postmenopausal single‐level KD patients who recei...
Main Authors: | Peng‐guo Gou, Zhi‐hui Zhao, Jia‐ming Zhou, Lin‐hui Ren, Xiao‐yun Wang, Yu‐feng Mu, Yun‐guo Wang, Feng Chang, Yuan Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Orthopaedic Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1111/os.12959 |
Similar Items
-
Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01) -
Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01) -
Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
by: Atsuyuki Kawabata, et al.
Published: (2020-07-01) -
Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
by: İnan Anaforoğlu, et al.
Published: (2013-12-01) -
Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
by: Virgínia Fernandes Moça Trevisani, et al.